pharmaceutical investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
pharmaceutical investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
pharmaceutical investing Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)
Silver47 and Summa Silver Announce Closing of $6.9 Million Brokered Financing, Including Full Exercise of the Over-Allotment Option
Hempalta Issues Open Call for Strategic Partnerships to Scale Alberta-Based Nature-Based Carbon Program